GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+5.2%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.01B
AUM Growth
+$1.01B
(+5.4%)
Cap. Flow
+$5.36M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
30.68%
Holding
182
New
9
Increased
49
Reduced
77
Closed
1
Top Buys
| 1 |
Blackbaud
BLKB
|
$2.12M |
| 2 |
Alcon
ALC
|
$1.17M |
| 3 |
ABB
ABB Ltd.
ABB
|
$1.01M |
| 4 |
Cognizant
CTSH
|
$988K |
| 5 |
US Bancorp
USB
|
$932K |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$1.59M |
| 2 |
Merck
MRK
|
$1.26M |
| 3 |
Microsoft
MSFT
|
$859K |
| 4 |
Amdocs
DOX
|
$787K |
| 5 |
RTX Corp
RTX
|
$635K |
Sector Composition
| 1 | Technology | 25.56% |
| 2 | Healthcare | 16.99% |
| 3 | Financials | 12.14% |
| 4 | Consumer Staples | 10.6% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Philip Morris
PM
$260B
| $829K | 0.08% |
10,561
-143
| -1% | -$11.2K |
|
|
102
DuPont de Nemours
DD
$32.2B
| $816K | 0.08% |
10,874
-21,125
| -66% | -$1.59M |
|
103
Intuitive Surgical
ISRG
$170B
| $811K | 0.08% |
1,546
| – | – |
|
104
Visa
V
$683B
| $798K | 0.08% |
4,600
-140
| -3% | -$24.3K |
|
105
Vanguard Large-Cap ETF
VV
$44.5B
| $765K | 0.08% |
5,680
+195
| +4% | +$26.3K |
|
106
SPDR Gold Trust
GLD
$107B
| $763K | 0.08% |
5,727
| – | – |
|
107
Incyte
INCY
$16.5B
| $756K | 0.07% |
8,895
+652
| +8% | +$55.4K |
|
108
Neurocrine Biosciences
NBIX
$13.8B
| $727K | 0.07% |
8,611
+730
| +9% | +$61.6K |
|
|
RDS.A
109
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $722K | 0.07% |
11,098
| – | – |
|
110
CSX Corp
CSX
$60.6B
| $704K | 0.07% |
9,100
| – | – |
|
111
Boeing
BA
$177B
| $702K | 0.07% |
1,928
-95
| -5% | -$34.6K |
|
112
Bristol-Myers Squibb
BMY
$96B
| $697K | 0.07% |
15,374
-277
| -2% | -$12.6K |
|
113
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $697K | 0.07% |
13,670
+900
| +7% | +$45.9K |
|
114
Eli Lilly
LLY
$657B
| $656K | 0.06% |
5,925
-200
| -3% | -$22.1K |
|
115
Charles Schwab
SCHW
$174B
| $647K | 0.06% |
16,092
| – | – |
|
116
BioMarin Pharmaceuticals
BMRN
$11.2B
| $645K | 0.06% |
7,533
+665
| +10% | +$56.9K |
|
117
Amazon
AMZN
$2.44T
| $625K | 0.06% |
330
+1
| +0.3% | +$1.89K |
|
118
Jacobs Solutions
J
$17.5B
| $614K | 0.06% |
7,277
-278
| -4% | -$23.5K |
|
119
McDonald's
MCD
$224B
| $600K | 0.06% |
2,887
-117
| -4% | -$24.3K |
|
120
Fiserv
FI
$75.1B
| $592K | 0.06% |
6,496
-800
| -11% | -$72.9K |
|
|
ALXN
121
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $584K | 0.06% |
4,460
+432
| +11% | +$56.6K |
|
122
NextEra Energy, Inc.
NEE
$148B
| $583K | 0.06% |
2,845
| – | – |
|
123
Omnicom Group
OMC
$15.2B
| $583K | 0.06% |
7,111
| – | – |
|
124
H.B. Fuller
FUL
$3.29B
| $561K | 0.06% |
12,094
| – | – |
|
125
Consolidated Edison
ED
$35.4B
| $539K | 0.05% |
6,146
| – | – |
|